Overview
This is a randomized controlled trial where patients undergoing surgical treatment for urogenital cancers will be randomized in a two arms study: surgical treatment + antibiotics OR surgical treatment + placebo.
Eligibility
Inclusion Criteria:
- Biopsy verified diagnosis of urological cancer, localized disease
Exclusion Criteria:
- Hospitalization within three months of surgery
- Antibiotics within three months of surgery
- Infectious disease, including UTI's within three months of surgery
- History of cancers of the genitourinary tract
- Diabetes